ConvaTec Group PLC (LON:CTEC) had its price target cut by Credit Suisse Group from GBX 280 ($3.68) to GBX 225 ($2.96) in a report published on Tuesday, October 17th. They currently have a neutral rating on the stock.
CTEC has been the subject of a number of other research reports. Citigroup Inc. reissued a neutral rating and set a GBX 290 ($3.81) price target on shares of ConvaTec Group PLC in a research report on Wednesday, October 11th. Goldman Sachs Group, Inc. (The) reissued a buy rating and set a GBX 340 ($4.47) price target on shares of ConvaTec Group PLC in a research report on Friday, June 30th. Numis Securities Ltd dropped their price target on shares of ConvaTec Group PLC from GBX 260 ($3.42) to GBX 250 ($3.29) and set a reduce rating for the company in a research report on Wednesday, August 9th. Deutsche Bank AG restated a buy rating and issued a GBX 330 ($4.34) price objective on shares of ConvaTec Group PLC in a report on Sunday, August 6th. Finally, J P Morgan Chase & Co restated an overweight rating and issued a GBX 303 ($3.99) price objective on shares of ConvaTec Group PLC in a report on Wednesday, September 20th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of Hold and an average price target of GBX 266.70 ($3.51).
ConvaTec Group PLC (LON:CTEC) traded up GBX 6.90 ($0.09) during trading on Tuesday, reaching GBX 188.90 ($2.48). 9,215,088 shares of the company were exchanged, compared to its average volume of 7,740,000. ConvaTec Group PLC has a twelve month low of GBX 181.98 ($2.39) and a twelve month high of GBX 349.10 ($4.59).
WARNING: “ConvaTec Group PLC (LON:CTEC) Price Target Cut to GBX 225 by Analysts at Credit Suisse Group” was first reported by BBNS and is the sole property of of BBNS. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://baseballnewssource.com/markets/credit-suisse-group-cuts-convatec-group-plc-ctec-price-target-to-gbx-225/1721378.html.
In related news, insider Frank Schulkes bought 50,000 shares of the stock in a transaction dated Tuesday, October 31st. The stock was purchased at an average cost of GBX 196 ($2.58) per share, with a total value of £98,000 ($128,896.49). Also, insider Christopher Gent bought 38,889 shares of the stock in a transaction dated Wednesday, October 18th. The shares were bought at an average cost of GBX 213 ($2.80) per share, with a total value of £82,833.57 ($108,948.53).
About ConvaTec Group PLC
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with our FREE daily email newsletter.